| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | CEO Level 15 +2 more
2 companies
Brett P Monia is Chief Executive Officer at IONS, with reported holdings spanning 2 companies. From January 2019 to August 2026, the filings on record show 0 open-market purchases and 35 sales. Brett P Monia's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $9.9M at current prices.
Our model assigns Brett P Monia a middling insider score of 63/100, based on 32 past trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of -13.1%.
Brett P Monia's largest disclosed position is in IONS as Chief Executive Officer, worth about $9.8M. The IONS filings lean toward selling, a net 923,101 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sell10b5-1 | 140 | $32.32 | $4,524.80 | - | +11.3% | +126.4% | |
| Feb 4, 2025 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sell10b5-1 | 38,843 | $31.65 | $1,229,462.52 | -17.7% | +6.3% | +168.6% | |
| Jan 31, 2025 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sell | 13,242 | $32.45 | $429,655.23 | -5.7% | -0.6% | +159.2% | |
| Jan 16, 2025 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 33,445 | $32.63 | $1,091,444.13 | -13.9% | -12.2% | +136.5% | |
| Nov 12, 2024 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sell10b5-1 | 6,630 | $38.05 | $252,294.04 | -3.8% | -16.7% | +92.4% | |
| Feb 16, 2024 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sell10b5-1 | 387 | $44.49 | $17,218.56 | -0.2% | -15.3% | -30.1% | |
| Feb 2, 2024 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sell | 23,501 | $49.37 | $1,160,303.12 | -11.9% | -13.4% | -35.9% | |
| Jan 25, 2024 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sell10b5-1 | 2,285 | $51.75 | $118,248.75 | -1.5% | -17.7% | -32.6% | |
| Jan 17, 2024 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 32,059 | $50.42 | $1,616,318.60 | -17.2% | -19.0% | -37.1% | |
| Dec 21, 2023 | IONS Ionis Pharmaceuticals Inc | Chief Executive Officer | Sale+OE10b5-1 | 24,000 | $49.38 | $1,185,219.85 | -16.9% | -12.9% | -27.4% |